密迪斯肌控股有限公司（08307）于2026年1月2日呈交的2025年12月股份变动月报显示，截至2025年12月31日，公司注册股本继续为10,000,000港元，对应1,000,000,000股普通股，票面价值每股0.01港元，未见任何增减。
截至本月末，已发行并在外流通的普通股数维持在396,736,000股，较上月底无新增发行或回购注销。公司购股权计划则保持39,673,600份股份期权，若未来行使，预计可增发相应数量普通股。截至2025年12月末，公司并无其他股份变动记录。
公司表示，确认上述股份变动事宜均遵守香港联合交易所有限公司相关上市规则及法律法规要求。公告由公司执行董事兼公司秘书冼翠碧签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.